Ethic Inc’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Sell |
54,632
-1,536
| -3% | -$120K | 0.08% | 268 |
|
|
2025
Q1 | $4.04M | Buy |
56,168
+15,775
| +39% | +$1.13M | 0.08% | 253 |
|
|
2024
Q4 | $2.99M | Sell |
40,393
-6,231
| -13% | -$461K | 0.06% | 320 |
|
|
2024
Q3 | $4.46M | Sell |
46,624
-5,931
| -11% | -$567K | 0.11% | 213 |
|
|
2024
Q2 | $4.85M | Buy |
52,555
+5,931
| +13% | +$548K | 0.11% | 192 |
|
|
2024
Q1 | $4.46M | Buy |
46,624
+8,329
| +22% | +$796K | 0.11% | 213 |
|
|
2023
Q4 | $2.92M | Buy |
38,295
+486
| +1% | +$37.1K | 0.09% | 276 |
|
|
2023
Q3 | $2.62M | Buy |
37,809
+2,266
| +6% | +$157K | 0.09% | 261 |
|
|
2023
Q2 | $3.35M | Buy |
+35,543
| New | +$3.35M | 0.12% | 204 |
|
|
2023
Q1 | – | Sell |
-35,065
| Closed | -$2.62M | – | 978 |
|
|
2022
Q4 | $2.62M | Sell |
35,065
-13,035
| -27% | -$973K | 0.14% | 189 |
|
|
2022
Q3 | $3.98M | Sell |
48,100
-2,856
| -6% | -$236K | 0.27% | 91 |
|
|
2022
Q2 | $4.85M | Buy |
50,956
+4,641
| +10% | +$441K | 0.34% | 65 |
|
|
2022
Q1 | $5.45M | Buy |
46,315
+6,650
| +17% | +$783K | 0.38% | 52 |
|
|
2021
Q4 | $5.14M | Buy |
39,665
+5,332
| +16% | +$691K | 0.4% | 53 |
|
|
2021
Q3 | $3.89M | Buy |
34,333
+3,623
| +12% | +$410K | 0.4% | 53 |
|
|
2021
Q2 | $3.18M | Buy |
30,710
+7,084
| +30% | +$734K | 0.39% | 53 |
|
|
2021
Q1 | $1.98M | Buy |
23,626
+6,645
| +39% | +$556K | 0.35% | 61 |
|
|
2020
Q4 | $1.55M | Buy |
16,981
+5,681
| +50% | +$518K | 0.41% | 48 |
|
|
2020
Q3 | $902K | Buy |
11,300
+3,014
| +36% | +$241K | 0.34% | 69 |
|
|
2020
Q2 | $573K | Buy |
8,286
+1,947
| +31% | +$135K | 0.33% | 78 |
|
|
2020
Q1 | $399K | Buy |
6,339
+339
| +6% | +$21.3K | 0.33% | 97 |
|
|
2019
Q4 | $467K | Buy |
+6,000
| New | +$467K | 0.34% | 98 |
|